Cargando…
Multiple myeloma: changes in serum C-terminal telopeptide of collagen type I and bone-specific alkaline phosphatase can be used in daily practice to detect imminent osteolysis*
Objective: Monitoring of bone disease in multiple myeloma is becoming increasingly important because bone-protecting treatment with bisphosphonate is becoming restricted after the awareness of osteonecrosis of the jaw. Despite the potential of biochemical markers of bone remodeling to monitor dynami...
Autores principales: | Lund, Thomas, Abildgaard, Niels, Andersen, Thomas L, Delaisse, Jean-Marie, Plesner, Torben |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2871171/ https://www.ncbi.nlm.nih.gov/pubmed/20070853 http://dx.doi.org/10.1111/j.1600-0609.2010.01417.x |
Ejemplares similares
-
First-line treatment with bortezomib rapidly stimulates both osteoblast activity and bone matrix deposition in patients with multiple myeloma, and stimulates osteoblast proliferation and differentiation in vitro
por: Lund, Thomas, et al.
Publicado: (2010) -
Expressions and clinical significance of serum bone Gla-protein, bone alkaline phosphatase and C-terminal telopeptide of type I collagen in bone metabolism of patients with osteoporosis
por: Zhao, Dongfeng, et al.
Publicado: (2015) -
Maternal type 1collagen N-terminal telopeptide levels in severe hyperemesis gravidarum
por: Sahin, E., et al.
Publicado: (2018) -
Value of C-telopeptide-cross-linked Type I collagen, osteocalcin, bone-specific alkaline phosphatase and procollagen Type I N-terminal propeptide in the diagnosis and prognosis of bone metastasis in patients with malignant tumors
por: Zhao, Hui, et al.
Publicado: (2011) -
Multiple Myeloma and Alkaline Phosphatase
por: Yavaşoğlu, İrfan, et al.
Publicado: (2015)